These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 24410402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
    Sheng J, Tian X, Xu G, Wu Z, Chen C, Wang L, Pan L, Huang C, Pan G.
    Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance.
    Abe K, Bridges AS, Yue W, Brouwer KL.
    J Pharmacol Exp Ther; 2008 Sep; 326(3):983-90. PubMed ID: 18574002
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
    Lepist EI, Gillies H, Smith W, Hao J, Hubert C, St Claire RL, Brouwer KR, Ray AS.
    PLoS One; 2014 Sep; 9(1):e87548. PubMed ID: 24498134
    [Abstract] [Full Text] [Related]

  • 12. Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.
    Szabó M, Veres Z, Bátai-Konczos A, Kékesi O, Kis E, Szabó K, Jemnitz K.
    Toxicol In Vitro; 2014 Sep; 28(6):1136-43. PubMed ID: 24909372
    [Abstract] [Full Text] [Related]

  • 13. Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates.
    Ferslew BC, Brouwer KL.
    Toxicol Sci; 2014 May; 139(1):99-107. PubMed ID: 24563379
    [Abstract] [Full Text] [Related]

  • 14. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin.
    Kitamura S, Maeda K, Wang Y, Sugiyama Y.
    Drug Metab Dispos; 2008 Oct; 36(10):2014-23. PubMed ID: 18617601
    [Abstract] [Full Text] [Related]

  • 15. Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes.
    Li N, Bi YA, Duignan DB, Lai Y.
    Mol Pharm; 2009 Oct; 6(4):1180-9. PubMed ID: 19545175
    [Abstract] [Full Text] [Related]

  • 16. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB.
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [Abstract] [Full Text] [Related]

  • 17. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.
    Marion TL, Perry CH, St Claire RL, Yue W, Brouwer KL.
    Toxicol Sci; 2011 Apr; 120(2):371-80. PubMed ID: 21262925
    [Abstract] [Full Text] [Related]

  • 18. Understanding the interplay of drug transporters involved in the disposition of rosuvastatin in the isolated perfused rat liver using a physiologically-based pharmacokinetic model.
    Hobbs M, Parker C, Birch H, Kenworthy K.
    Xenobiotica; 2012 Apr; 42(4):327-38. PubMed ID: 22035568
    [Abstract] [Full Text] [Related]

  • 19. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS, Feng B, Nguyen HT, Frederick KS, Campbell SD, Hatch HL, Bi YA, Kazolias DC, Davidson RE, Mireles RJ, Duignan DB, Choo EF, Zhao SX.
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
    Hartman JC, Brouwer K, Mandagere A, Melvin L, Gorczynski R.
    Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.